UM: Stem Cells

By

The Detroit News reports that University of Michigan researchers and Dr. Mark Hughes, president of Genesis Genetics in Detroit, have created two new stem cell lines, which will aid in the research of two hereditary diseases: hemophilia B and Charcot-Marie-Tooth disease. The article quotes Gary Smith, co-director of the UM Consortium for Stem Cell Therapies: “These cells aren’t necessarily going to drive us toward discoveries of stem cell replacement therapies, but will give us information we’ve never had before with regards to how the diseases form and progress.” [Source]